← Search

Data · dataset · 2025

Enasidenib mesylate

Listed in Virginia Open Data Portal

Description

Idhifa (enasidenib mesylate) is a prescription oral tablet that inhibits the IDH2 enzyme, used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have an IDH2 mutation. Available in 50mg and 100mg strengths. This information was generated using AI and is provided for informational and research purposes only. --- ### 🔗 Related Datasets - Enasidenib mesylate — *HealthData.Gov* - Imatinib mesylate — *HealthData.Gov* - Imatinib mesylate — *HealthData.Gov* - Eribulin mesylate — *HealthData.Gov* - Eribulin mesylate — *HealthData.Gov* ---

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portal32f21a7e-d937-4bbc-a4d1-003808500e6a3 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].anzsrc:group:4206mapping · data virginia govvocabulary-mapper@1.0.0keywords['public-health']
concepts[field].local:field:engineeringmapping · data virginia govconnector:data_virginia_gov@1.0.0
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0